Eledon Pharmaceuticals Inc

ELDNNASDAQ · USD
2.89USD0.00 (+7.44%)
117

Eledon Pharmaceuticals Inc (ELDN) Option Chain

As of September 21, 2026, Eledon Pharmaceuticals Inc is trading at $2.89, a +7.44% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 205.4%. IV Rank is 73%.

Read more

Tracking the ELDN option chain helps you see every strike and expiry on Eledon Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Eledon Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ELDN options activity at a glance. Use our scanner to monitor the ELDN option chain in real time and filter for the ELDN options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ELDN stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ELDN option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ELDN stock options are being actively traded and where they are not.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc.

and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Eledon Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ELDN options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ELDN stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile82.54% Elevated
  • Market cap (M$)235
  • 52 weeks high-37.17%
  • 52 weeks low114.07%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$9.50
    228.72% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-13
  • P/E
  • Future P/E
  • EPS (ttm)-0.99
  • EPS growth next 5 years-17.33%

As of September 21, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
56.875900.560.390.952.50-7.060.300.000.300043.13
90.8122801.000.001.005.00+85.872.003.002.110.39009.19
97.75001.000.001.007.50+178.814.405.404.610.29002.25

As of September 21, 2026

Scan the full option chain in one place

Browse the full ELDN option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial